CLASP5 (renewed online): pilot and randomised controlled trialPrevious title: CLASP Renewed Online Feasibility Study
- Conditions
- Malignant neoplasms of independent (primary) multiple sitesCancer
- Registration Number
- ISRCTN96374224
- Lead Sponsor
- niversity of Southampton
- Brief Summary
2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/30826763 protocol (added 30/03/2020)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 2728
Current inclusion criteria as of 15/03/2018:
1. Aged 18 years or over
2. Identifiable from GP case records
3. Have had breast, prostate or colorectal cancer.
4. Have finished primary cancer treatment (e.g. chemotherapy/radiotherapy courses) within last 10 years and primary treatment completed at least 1 month ago. This does not include active surveillance for prostate cancer patients or hormone therapy for any participants.
5. Have internet access
6. Have impaired quality of life (measured by EORTC)
Previous inclusion criteria
1. Be aged 18 yrs
2. Be identifiable from GP case records
3. Have had breast, prostate or colorectal cancer.
4. Have finished primary cancer treatment (eg chemotherapy/radiotherapy courses) within last 10 years. This does not include active surveillance for prostate cancer patients or hormone therapy for any participants.
5. Have internet access
6. Have impaired quality of life
Current exclusion criteria as of 15/03/2018:
1. Currently have cancer
2. Have had more than one other type of cancer (other than breast, prostate or colon) in the last 5 year
3. Have metastatic cancer
4. Receiving any cancer treatment other than hormone therapy currently or during the last month
5. Expecting to start any cancer treatment during the study period
6. Have severe mental health problems and/or major uncontrolled depression/schizophrenia or dementia
7. Had sarcoma/lymphoma of breast
8. Another participant of the study living in the same household
9. Currently have untreated cancer unless on active surveillance for prostate cancer
Previous exclusion criteria
1. Currently have cancer
2. Have had more than one other type of cancer (other than breast, prostate or colon) in the last 5 year
3. Have metastatic cancer
4. Receiving any cancer treatment other than hormone therapy currently or during the last month
5. Expecting to start any cancer treatment during the study period
6. Have severe mental health problems and/or major uncontrolled depression/schizophrenia or dementia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method